Oxford MEStar

Name

Oxford MEStar

Legal name

Oxford MEStar Ltd

Website

https://oxford-mestar.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Biotechnology and Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing) (HLAMANAI), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Molecular diagnostics
• 3D bioprinting
• Regenerative medicine
• Bioreactor systems
• In-vitro diagnostics

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

1. In-Vitro Diagnostic Products: Sale of measure bowel health digital at-home testing kits for detecting invisible traces of blood in stool. Revenue from consumer direct purchases via e-commerce and Amazon marketplace.
2. Bioengineering Products and Solutions: Sale of cell expansion bioreactors, automated decellularisation systems, and 3D bioprinting products/services including OME Flex scaffolds and PetAssist veterinary services.
3. Technology Transfer Services: Providing bioengineering expertise and solutions to clients, including technology transfer between UK and China for biotechnology companies seeking market entry.
4. IP Licensing and Acquisition: Revenue from acquired intellectual property including Mode Diagnostics electrochemical detection platform for developing diagnostic products for other cancers and infectious diseases.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Oxford MEStar develops and sells molecular diagnostics products and biotechnology platforms for translational and regenerative medicine. Its core offerings include the measure bowel health digital at-home testing kit and measurePRO (clinical version) using patented electrochemical detection technology, 3D bioprinting products (OMEFlex), automated cell expansion bioreactors and decellularisation systems for cell therapy manufacturing, and lab reagent supplies (PCR/LAMP enzymes, lateral flow devices, pipette tips, DNA/RNA extraction kits). The company also provides veterinary bioprinting services (PetAssist) and UK-China technology transfer services for biotech companies.

Product overview

Oxford MEStar is a spin-out from Oxford University's Institute of Biomedical Engineering specializing in molecular diagnostics and biotechnology. The company operates across four main product areas: (1) In Vitro Diagnostics including measure bowel health (home testing kit) and measurePRO (professional version) using patented electrochemical detection technology; (2) 3D Bioprinting featuring OMEFlex (bioprinting constructs) and PetAssist (animal treatment service); (3) Regenerative Medical Technologies including cell expansion bioreactors, auto-decellularisation systems, and stem cell technology; and (4) Lab Reagent Supplies covering PCR/LAMP enzymes, filtered pipette tips, lateral flow devices, and DNA/RNA extraction kits. The company leverages proprietary electrochemical detection technology acquired from Mode Diagnostics and maintains manufacturing through its Chinese partner Scottech Medical in Tianjin.

Differentiator

Problem solved

Functional benefit

Brands

• measure: Digital at-home testing kit for bowel health detection using patented electrochemical technology; includes measure and measurePRO products
• OME Flex
• PetAssist

Products and services

• measure bowel health First and only digital at-home testing kit for the detection of invisible traces of blood in stool using patented electrochemical technology; designed to be fast, discreet, hygienic and simple, with digital results in less than a minute, targeting individual consumers for early bowel cancer and gastrointestinal disease screening.
• measurePRO Professional version of the digital bowel cancer testing device designed for clinical and professional healthcare use, built on the same patented electrochemical detection platform as the consumer measure bowel health kit.
• OMEFlex 3D bioprinting product for fabricating tissue-like three-dimensional biological constructs, using hydrogel/cells dispensed onto biocompatible scaffolds via a precise dispensing system coupled to modified 3D printing technology; targets regenerative medicine and tissue engineering labs.
• PetAssist Personalised 3D bioprinting service for animal post-cancer treatment, utilising clinical CT imaging data to reconstruct defects and create custom veterinary implants.
• Cell expansion bioreactors Closed automated bioreactor system for large-scale cell and stem cell expansion, featuring high cell density production and automated monitoring and adjustment of culture parameters; targets cell therapy manufacturers and regenerative medicine labs.
• Auto-decellularisation systems Automated natural tissue decellularisation systems for scale-up and production of natural tissue decellularised scaffolds under GMP conditions, with programmable control of temperature, buffer change, and waste disposal.
• PCR/LAMP enzymes and reagents PCR and LAMP enzymes and reagents for molecular diagnostics and research applications, sold for laboratory use.
• Filtered pipette tips High-standard filtered pipette tips engineered to block aerosols and prevent cross-contamination for critical samples and PCR reactions, available in P10, P20, P100, P200, and P1000 sizes.
• Lateral Flow Device Engineered lateral flow device for accurate measurement of targets, featuring an internal control to prevent false positives, with results available in as little as 5 minutes.
• DNA/RNA extraction kit Pre-filled ready-to-use deep-well plates for fast DNA/RNA extraction from various sample types, compatible with most automatic extraction instruments.
• Real-time PCR systems Real-time PCR systems available in 16-well and 48-well configurations for molecular diagnostics applications.

Quantifiable outcome

• Early detection enables 9 in 10 people to survive bowel cancer for 5+ years when caught at stage one
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

14 partnerships are on record, tiered core, major and minor.

• Scottech Medical Co. LtdcoreStrategic or Co-development Partner · 1 January 2016Sister company established in Tianjin, China in 2016. Operates 1200m2 GMP medical device manufacturing facility (extendable to 3000m2) with ISO 9001 and ISO 13485 certification. Manufactures products developed by Oxford MEStar and functions as sales/marketing office for China and Far East region.
• University of OxfordcoreStrategic or Co-development PartnerOxford MEStar is a spin-out from the Institute of Biomedical Engineering of Oxford University. Maintains ongoing collaborative R&D projects with the university.
• UCL (University College London)majorStrategic or Co-development PartnerOngoing collaboration with interdisciplinary UCL team from Division of Surgery & Interventional Science on osteochondral scaffold technology and tissue engineering projects.
• Cell and Gene Therapy CatapultmajorStrategic or Co-development PartnerUK independent centre of excellence bridging scientific research and commercialisation of cell and gene therapy. Partner in Innovate UK-Jiangsu grant for CAR-T manufacturing system development. Provides expert design and testing through exemplar immunotherapy processes.
• AK (Suzhou) BiomedicalmajorStrategic or Co-development PartnerChinese biotech firm specialising in cell therapy and regenerative medicine products and services. Industrial lead in China for CAR-T manufacturing project. Provides validation in GMP environment and pre-production prototyping.
• Collagen Solutions plcmajorStrategic or Co-development PartnerDeveloper and manufacturer of medical grade collagen components for regenerative medicine, medical devices, and in-vitro diagnostics. Partner in Arthritis Research UK grant for osteochondral scaffold development.
• Tianjin Weikai Bioeng LtdminorStrategic or Co-development PartnerChinese partner for ongoing collaborative projects in bioprocessing and bioengineering.
• Interreg 2 Seas 3DMEd ConsortiummajorStrategic or Co-development PartnerEU-funded 36-month project (€6.84M total budget) involving 15 partners across Netherlands, Belgium, France, and UK to develop and streamline integration of 3D printing technologies for advanced medical treatment. Oxford MEStar contributes 3D bioprinting expertise.
• UniNova LtdminorStrategic or Co-development PartnerSister company incorporated in November 2014 with 80 million RMB private investment and support from Tianjin Municipal Government. Provides one-stop solution for SMEs in biotechnology seeking to enter Chinese market.
• Elanix Biotechnologies AGminorStrategic or Co-development PartnerSwiss biotech company developing tissue regeneration products. Non-binding LOI announced November 2016 for potential JV with UniNova to market GynRepair in China.
• Bowel & Cancer ResearchminorOthersUK charity and leading research authority in bowel disease. Oxford MEStar donates a proportion of each measure bowel health kit sold to support vital research.
• Tsinghua UniversityminorStrategic or Co-development PartnerChinese university partner in £2m Innovate UK-MoST grant for osteochondral scaffold technology development.
• Shenzhen Lando Co. LtdminorStrategic or Co-development PartnerChinese partner in Innovate UK-MoST grant for osteoarthritis treatment development.
• Mode Diagnostics LtdcoreTechnology or IntegrationUniversity of Glasgow spin-out from which Oxford MEStar acquired selected IP, trademarks, and assets including electrochemical detection technology platform for in-vitro diagnostics.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• BICO (formerly CELLINK): Swedish-headquartered 3D bioprinting and lab automation company with a portfolio spanning bioprinters, bioreactors, reagents, and diagnostics. Directly comparable to Oxford MEStar's combined bioprinting (OME Flex), bioreactor, IVD, and reagent offering, though much larger and publicly listed.
• Sartorius AG: Global bioprocessing equipment and consumables leader serving cell and gene therapy manufacturing. Comparable as a broader bioprocess automation incumbent whose automated bioreactor offerings overlap with Oxford MEStar's cell-expansion bioreactors in the same end markets.
• Cytiva (Danaher): Global life-sciences tools and bioprocessing company offering bioreactors, single-use solutions, and regenerative-medicine workflows. Comparable broad-incumbent in bioprocess equipment, cell-therapy manufacturing, and laboratory consumables relevant to Oxford MEStar's products.

Emerging players

• Oxsed: Oxford University spin-out developing rapid molecular diagnostics, also founded by Prof Cui, with parallel focus on point-of-care test technology. Closely comparable to Oxford MEStar's measure bowel health diagnostics line and shared scientific lineage.
• Collagen Solutions plc: Developer and manufacturer of medical-grade collagen components for regenerative medicine, medical devices, and IVD. Highly comparable as a biomaterials platform that collaborates with Oxford MEStar on the osteochondral scaffold program.

Direct peers

• PBS Biotech: Single-use, automated cell-expansion bioreactor company serving cell and gene therapy manufacturing. Directly comparable to Oxford MEStar's automated cell expansion bioreactor product targeting CAR-T and stem-cell therapy manufacturing cost reduction.
• Organovo Holdings: Pioneer in 3D bioprinting human tissue constructs for therapeutic and research use. Highly comparable to Oxford MEStar's OME Flex bioprinting product and tissue-engineering roadmap, though focused specifically on the therapeutic tissue segment.
• CN Bio Innovations: Oxford-based organ-on-chip and bioengineering company also founded by Prof Zhanfeng Cui. Highly comparable as a translation-stage bioengineering spin-out leveraging Oxford IP, with overlapping expertise in tissue/bioprocess engineering and similar grant-backed commercial strategies.
• Elanix Biotechnologies: Swiss tissue-regeneration company developing biological products for wound healing and gynaecological repair. Comparable regenerative-medicine focus and was previously in a documented LOI with Oxford MEStar/UniNova for Chinese market entry.
• AK (Suzhou) Biomedical: Chinese cell-therapy and regenerative-medicine company serving as Oxford MEStar's industrial lead in China for the CAR-T manufacturing project. Highly comparable as a peer in the UK-China cell-therapy corridor and a direct commercialisation collaborator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/OxfordMEStar
• Facebookfacebook.com/oxfordmestar

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford MEStar